iShares Nasdaq US Biotechnology UCITS ETF (BTEE.L) — ETF Analysis on Winston
Key Facts
- Issuer: IShares
- Category: Equity
- Asset Class: Equity
- Price: $10.60
- Expense Ratio: 35.00%
- Assets Under Management: $77M
- Number of Holdings: 254
- Inception Date: 2018-03-05
- Currency: GBP
Winston Score
iShares Nasdaq US Biotechnology UCITS ETF has a Winston Score of 67 out of 100.
Performance
- 1-Year Return: 41.23%
- 3-Year Return: 42.64%
- 5-Year Return: 18.31%
Top Holdings
AMGEN INC (N/A%), VERTEX PHARMACEUTICALS INC (N/A%), GILEAD SCIENCES INC (N/A%), REGENERON PHARMACEUTICALS INC (N/A%), REVOLUTION MEDICINES INC (N/A%)
Sector Breakdown
Healthcare (N/A%)